Overall survival and local recurrence following RFA, MWA, and cryoablation of very early and early HCC: a systematic review and Bayesian network meta-analysis

P Gupta, M Maralakunte, P Kumar-M, K Chandel… - European …, 2021 - Springer
Objective To compare overall survival (OS) and local recurrence (LR) following
radiofrequency ablation (RFA), microwave ablation (MWA), and cryoablation (CA) for very …

Non-surgical locoregional therapies alone or in combination with systemic therapy in patients with hepatocellular carcinoma

P Chami, W Jarnagin, GK Abou-Alfa, J Harding, N Kim… - Cancers, 2023 - mdpi.com
Simple Summary Ablation, arterially directed therapies and external beam radiation therapy
are among the locoregional therapies considered for patients with hepatocellular carcinoma …

The increasing role of CT-guided cryoablation for the treatment of liver cancer: A single-center report

C Pusceddu, L Mascia, C Ninniri, N Ballicu, S Zedda… - Cancers, 2022 - mdpi.com
Simple Summary Image-guided percutaneous ablation of primary and metastatic liver
tumors has been gaining importance in patients who are not suitable for hepatic resection or …

Local-regional treatment of hepatocellular carcinoma: A primer for radiologists

N Horvat, AI De Oliveira, B Clemente de Oliveira… - …, 2022 - pubs.rsna.org
The treatment planning for patients with hepatocellular carcinoma (HCC) relies
predominantly on tumor burden, clinical performance, and liver function test results. Curative …

Loco-regional treatments for hepatocellular carcinoma in people living with HIV

C Micali, Y Russotto, G Caci, M Ceccarelli… - Infectious Disease …, 2022 - mdpi.com
Hepatocellular carcinoma (HCC) accounts for approximately 75–90% of primary liver
cancers and is the sixth most common cancer and the third leading cause of cancer-related …

What's new in percutaneous ablative strategies for hepatocellular carcinoma and colorectal hepatic metastases? 2020 Update

RS Arellano - Current Oncology Reports, 2020 - Springer
Abstract Purpose of Review Ablation techniques are now well-established treatment options
available for the management of primary and secondary hepatic malignancies. Currently …

Percutaneous cryoablation of liver tumors: initial experience from a tertiary care center in India

N Kalra, P Gupta, T Jugpal, SS Naik, U Gorsi… - Journal of Clinical and …, 2021 - Elsevier
Background Percutaneous ablation is an important part of management strategy for liver
tumors. While radiofrequency ablation and microwave ablation are the most widely used …

[HTML][HTML] Irreversible electroporation for hepatocellular carcinoma abutting the diaphragm: a prospective single-center study

Y Ma, Z Chen, B Liang, R Li, J Li, Z Li… - Journal of Clinical and …, 2022 - ncbi.nlm.nih.gov
Methods A total of 26 participants with 39 tumors abutting the diaphragm were prospectively
evaluated between July 2015 and September 2018. Complications associated with IRE …

Percutaneous Cryoablation: Mechanism of Action, Clinical Applications, and Outcomes

A Farhan, CR Bailey… - The Application of Heat in …, 2023 - Wiley Online Library
Image‐guided, percutaneous cryothermal ablation has become a critical modality for the
treatment of a variety of malignant and non‐malignant indications. This minimally invasive …

Thermal Ablation in the Liver: Heat versus Cold—What Is the Role of Cryoablation?

DL D'Souza, R Ragulojan, C Guo… - Seminars in …, 2023 - thieme-connect.com
Cryoablation is commonly used in the kidney, lung, breast, and soft tissue, but is an
uncommon choice in the liver where radiofrequency ablation (RFA) and microwave ablation …